Viravaxx AG has a total of 14 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ONCOGENE SCIENCE INC, VIB VZW and CHUGAI RES INST MOLECULAR MED.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Hong Kong | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Philippines | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Valenta Rudolf | 13 |
#2 | Cornelius Carolin | 9 |
#3 | Gallerano Daniela | 2 |
#4 | Niederberger-Leppin Verena | 2 |
#5 | Sibanda Elopy N | 2 |
#6 | Niespodziana Katarzyna | 2 |
#7 | Papadopoulos Nikos | 2 |
#8 | Edlmayr Johanna | 2 |
#9 | Blaas Dieter | 2 |
#10 | Popow-Kraupp Theresia | 2 |